| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489430 Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 02/06/1996 | CA2056437C Production of virus and purification of viral envelope proteins for vaccine use |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002658A1 A method for large scale plasmid purification |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002654A1 Toxoplasma gondii p30 protein expression cassette |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002575A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1996002264A2 Chlorine dioxide-containing compositions for use in the eye |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1995035112A3 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | CA2194873A1 Condii toxoplasma p30 expression cassette |
| 02/01/1996 | CA2194784A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | CA2192342A1 A method for large scale plasmid purification |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0694066A1 Model for gonococcal infection |
| 01/31/1996 | EP0694043A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 01/31/1996 | EP0693938A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 01/31/1996 | EP0693937A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/31/1996 | EP0491688B1 Methods for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
| 01/31/1996 | EP0305488B1 Mycobacterial recombinants and peptides |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | CA1338028C Synthetic peptide antigens for the detection of hiv-1 infection |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001900A1 Immunodominant polypeptides |
| 01/25/1996 | WO1996001891A1 Method for generating a population of cells having a high surface density of a mhc molecule-associated specific exogenous peptide, and cell population |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001651A1 Attenuated human rotavirus vaccine |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | WO1996001620A1 Method of priming an immune response in a one-day old animal |
| 01/25/1996 | WO1996001615A2 Hepatitis a virus deletion mutants and vaccine formulations containing the same |
| 01/25/1996 | WO1996001611A1 Implanted device containing tumor cells for the treatment of cancer |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/24/1996 | EP0693551A1 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/24/1996 | EP0693183A1 Methods for diabetes susceptibility assessment in asymptomatic patients |
| 01/24/1996 | EP0693132A1 Rapamycin assay |
| 01/24/1996 | EP0693125A1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
| 01/24/1996 | EP0693120A1 Tumoricide t lymphocytes |
| 01/24/1996 | EP0692974A1 Multicomponent clostridial vaccines using saponin adjuvants |
| 01/24/1996 | EP0692973A1 Peptide coated dendritic cells as immunogens |
| 01/24/1996 | EP0692969A1 Method of treatment of diseases by deletion of t cells |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
| 01/23/1996 | US5486596 Analogues of 8-D-homoarginine vasopressin |
| 01/23/1996 | US5486473 Genetic engineering |
| 01/23/1996 | US5486453 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |
| 01/23/1996 | CA1338001C Synthetic peptide antigens for the detection of htlv-1 infection |
| 01/23/1996 | CA1337971C Products and processes for increasing the growth rate and /or utilization of feeds or foods and/or resistance in animals and humans |
| 01/20/1996 | CA2128364A1 Anti-protein mediator therapeutic kits, a preparation method and pharmaceutical compositions containing them |
| 01/19/1996 | CA2154030A1 Gd-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001122A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/18/1996 | WO1995034323A3 Proteinaceous adjuvants |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194239A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/17/1996 | EP0692532A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
| 01/17/1996 | EP0692491A1 Human virus-free monomeric immunoglobulin A and method for its production |
| 01/17/1996 | EP0692488A2 Interleukin 4 signal transducers and binding assays |
| 01/17/1996 | EP0692031A1 Heterologous antigens in live cell vaccine strains |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |